These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Author: Meterissian GB.
    Journal: Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425.
    Abstract:
    OBJECTIVES: 1. To report the case of a 53-year-old patient who developed neuroleptic malignant syndrome (NMS) - a rare but potentially life-threatening complication of neuroleptic therapy - 4 days after treatment with risperidone was initiated. 2. To review previously reported cases of NMS associated with risperidone. METHODS: A computerized search of several databases, including MEDLINE, was conducted to find all previously reported cases of NMS with risperidone. RESULTS: Five reported cases of risperidone-induced NMS were found in the literature. All cases including the one reported here displayed typical clinical features of NMS and all 6 patients had a prior history of extrapyramidal side effects and/or NMS. Age and duration of exposure to risperidone did not seem to be of significance. CONCLUSIONS: These cases illustrate that clinicians should be on the lookout for risperidone-induced NMS.
    [Abstract] [Full Text] [Related] [New Search]